Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study

Gian Luca Poli, Claudia Bianchi, Giorgio Virotta, Anna Bettini, Renzo Moretti, Eveline Trachsel, Giuliano Elia, Leonardo Giovannoni, Dario Neri and Andrea Bruno
Gian Luca Poli
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Bianchi
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgio Virotta
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Bettini
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renzo Moretti
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eveline Trachsel
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuliano Elia
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Giovannoni
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dario Neri
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Bruno
1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/2326-6066.CIR-13-0007 Published August 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: May 2013 to January 2021

AbstractFull-text HTMLPDF
Total331231571780

Cited By

Article Information

Volume 1, Issue 2, pp. 134-143

DOI 
https://doi.org/10.1158/2326-6066.CIR-13-0007
PubMed 
24777501

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received February 10, 2013
  • Revision received March 26, 2013
  • Accepted March 30, 2013
  • Published first May 20, 2013.

Article Versions

  • Previous version (May 20, 2013 - 09:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2013 American Association for Cancer Research.

Author Information

  1. Gian Luca Poli1,
  2. Claudia Bianchi1,
  3. Giorgio Virotta1,
  4. Anna Bettini1,
  5. Renzo Moretti1,
  6. Eveline Trachsel3,
  7. Giuliano Elia3,
  8. Leonardo Giovannoni2,
  9. Dario Neri4, and
  10. Andrea Bruno1
  1. Authors' Affiliations: 1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
  1. Corresponding Authors:
    Gian Luca Poli, Department of Medical Physics, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. Phone: 39-035-2674266; Fax: 39-035-2674798; E-mail: glpoli{at}hpg23.it; and Dario Neri, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland. Phone: 41-44-633-74-01; Fax: 41-44-633-13-58; E-mail: neri{at}pharma.ethz.ch
View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 1 (2)
August 2013
Volume 1, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
Gian Luca Poli, Claudia Bianchi, Giorgio Virotta, Anna Bettini, Renzo Moretti, Eveline Trachsel, Giuliano Elia, Leonardo Giovannoni, Dario Neri and Andrea Bruno
Cancer Immunol Res August 1 2013 (1) (2) 134-143; DOI: 10.1158/2326-6066.CIR-13-0007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
Gian Luca Poli, Claudia Bianchi, Giorgio Virotta, Anna Bettini, Renzo Moretti, Eveline Trachsel, Giuliano Elia, Leonardo Giovannoni, Dario Neri and Andrea Bruno
Cancer Immunol Res August 1 2013 (1) (2) 134-143; DOI: 10.1158/2326-6066.CIR-13-0007
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • CD28 Mutation Enhances CAR T-cell Function
  • ICV-Delivered CD19-CAR T Cells for CNS and Systemic Lymphoma
  • Activin A Mediates Radiation-Induced Antitumor Immunity
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement